ArticleBiomarker research2023

Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia.

Yvyin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.